Table 2.
4:1 | MP | DN | HTK | p-Value | |
---|---|---|---|---|---|
Observations | 8,350 | 4,606 | 3,344 | 370 | |
Net prime volume (mL)—median [IQR] | 760 [625, 900] | 660 [510, 820] | 655 [500, 900] | 675 [525, 875] | <.001 |
CPB added crystalloid (mL)—median [IQR] | 283 [82, 700] | 314 [105, 700] | 225 [60, 550] | 915 [343, 1,260] | <.001 |
Urine output on CPB (mL)—median [IQR] | 250 [130, 400] | 200 [125, 350] | 200 [110, 350] | 230 [135, 350] | <.001 |
Ultrafiltration used—n (%) | 2,842 (34.0) | 1,895 (41.1) | 2,799 (83.7) | 314 (84.9) | <.001 |
Ultrafiltration volume when used (mL)—median [IQR] | 1,500 [1,000, 2,300] | 1,200 [700, 1,800] | 2,000 [1,300, 3,000] | 2,900 [2,205, 3,600] | <.001 |
Anesthesia crystalloid volume (mL)—median [IQR] | 1,500 [1,100, 2,000] | 1,500 [1,000, 1,900] | 1,000 [1,000, 1,550] | 1,300 [1,000, 1,700] | <.001 |
CPB time (minutes)—median [IQR] | 100 [77, 133] | 103 [77, 138] | 91 [69, 122] | 104 [81, 132] | <.001 |
Cross clamp time (minutes)—median [IQR] | 73 [55, 98] | 77 [54, 105] | 66 [48, 90] | 82 [64, 100] | <.001 |
CPB, cardiopulmonary bypass; DN, del Nido; HTK, histidine-tryptophan-ketoglutarate; IQR, interquartile range; MP, microplegia; 4:1, 4–1 blood to crystalloid.